SARS-CoV-2 Viral Load in the Nasopharynx at Time of First Infection Among Unvaccinated Individuals
Leigh H. Fisher(Fred Hutch Cancer Center), Terry D. Klein, James P. Ludwig, Amber Grant, S Green, Yunda Huang(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Glenda Gray(South African Medical Research Council), Stephen R. Walsh(Beth Israel Deaconess Medical Center), Beatriz Grinsztejn(Fundação Oswaldo Cruz), Karen L. Kotloff(University of Maryland, Baltimore), Paul Goepfert(University of Maryland, Baltimore), Marshall Nash, James G. Kublin(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Craig A. Magaret(Fred Hutch Cancer Center), Jerald Sadoff(University of Maryland, Baltimore), April K. Randhawa(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Nadine Rouphael(Emory University), Hana M. El Sahly(Baylor College of Medicine), Terry L. Poling, Cynthia L. Gay(University of North Carolina at Chapel Hill), Stacy Slechta, Holly Janes(Fred Hutch Cancer Center), Kathleen M. Neuzil(Center for Global Development), Frank Struyf(Janssen (Belgium)), Albert Liu(San Francisco Department of Public Health), Steven Shinn, Dean Follmann(National Institute of Allergy and Infectious Diseases), Jacqueline M. Miller(Moderna Therapeutics (United States)), Lawrence Corey(Fred Hutch Cancer Center), Claudia Espinosa(University of Louisville), Brett Leav(University of Maryland, Baltimore), Samuel T. Robinson(Columbia University), Lisa M. Dunkle(Merck & Co., Inc., Rahway, NJ, USA (United States)), Robyn Hartvickson, Peter B. Gilbert(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Magdalena E. Sobieszczyk(Columbia University Irving Medical Center), Ollivier Hyrien(Fred Hutch Cancer Center), Ann R. Falsey(University of Rochester), Jia Jin Kee(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Lindsey R. Baden(Brigham and Women's Hospital), Sikhongi Phungwayo, Troy Holdeman, Bruce G. Rankin, Jayasree Krishnankutty, Richard Glover, Colleen Jacobsen, Eric N. Miller, Atoya Adams, Ian Hirsch(AstraZeneca (United Kingdom))
Cited by 6
Related Papers
Prevention of HIV-1 Infection with Early Antiretroviral Therapy
|New England Journal of Medicine|2011|7k
Safety and Immunogenicity of Two RNA-Based Covid-19 Vaccine Candidates
|New England Journal of Medicine|2020|2.7k
Safety and Efficacy of Single-Dose Ad26.COV2.S Vaccine against Covid-19
|New England Journal of Medicine|2021|2.6k
Respiratory Syncytial Virus Infection in Elderly and High-Risk Adults
|New England Journal of Medicine|2005|2.2k